Learn more

MAX DELBRUCK CENTRUM FUR MOLEKULARE MEDIZIN IN DER HELMHOLTZ GEMEINSCHAFT

Overview
  • Total Patents
    19
  • GoodIP Patent Rank
    88,963
  • Filing trend
    ⇩ 62.0%
About

MAX DELBRUCK CENTRUM FUR MOLEKULARE MEDIZIN IN DER HELMHOLTZ GEMEINSCHAFT has a total of 19 patent applications. It decreased the IP activity by 62.0%. Its first patent ever was published in 2015. It filed its patents most often in Canada, China and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT, ALFACELL CORP and TRIMERIS INC.

Patent filings in countries

World map showing MAX DELBRUCK CENTRUM FUR MOLEKULARE MEDIZIN IN DER HELMHOLTZ GEMEINSCHAFTs patent filings in countries
# Country Total Patents
#1 Canada 9
#2 China 5
#3 Australia 2
#4 Republic of Korea 2
#5 Israel 1

Patent filings per year

Chart showing MAX DELBRUCK CENTRUM FUR MOLEKULARE MEDIZIN IN DER HELMHOLTZ GEMEINSCHAFTs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Izsvak Zsuzsanna 4
#2 Uckert Wolfgang 4
#3 Blankenstein Thomas 3
#4 Kaufmann Christopher 3
#5 Ivics Zoltan 3
#6 Narayanavari Suneel 3
#7 Karaiskos Nikolaos 2
#8 Willimsky Gerald 2
#9 Rehm Armin 2
#10 Nazare Marc 2

Latest patents

Publication Filing date Title
CA3111045A1 A method for engineering synthetic cis-regulatory dna
CA3112262A1 Full-length rna sequencing
CA3082610A1 Methods for modulating pigmentation by angiotensin-converting enzyme 2 modulation
KR20200039783A Chimeric antigen receptor and CAR-T cells that bind CXCR5